Company/Division name | Celltrion |
Parent company | Celltrion Holdings |
Type of work | Manufacturing |
Reshoring category: | Foreign Direct Investment |
Year reshoring announced: | 2025 |
Year reshoring implemented or to be implemented: | 2025 |
Domestically, the work will be done: | In-house |
Capital investment ($): | 330 |
Country(ies) from which reshored: | Korea, South |
City reshored to: | Branchburg |
State(s) reshored to: | NJ |
If relevant, work nearshored to: | - |
Industry(ies): | Chemicals |
Product(s) reshored | pharmaceuticals |
What non-domestic negative factors made offshoring less attractive? | Tariffs |